Wei R, Shi X, Qiu W, Yang M, Chen Y, Song S
Sci Rep. 2025; 15(1):7868.
PMID: 40050358
PMC: 11885642.
DOI: 10.1038/s41598-025-92317-w.
Wang L, Zhang M, Zhao K, Yuan X, Zhao H, Liu Y
Front Oncol. 2025; 15:1451130.
PMID: 40046628
PMC: 11881191.
DOI: 10.3389/fonc.2025.1451130.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F
Nature. 2025; .
PMID: 40044861
DOI: 10.1038/s41586-025-08671-2.
Liu Y, Mo W, Sun W, Chen J, Chen J, Li Y
Dig Dis Sci. 2025; .
PMID: 40038210
DOI: 10.1007/s10620-025-08890-7.
Papaccio F, Cabeza-Segura M, Garcia-Mico B, Gimeno-Valiente F, Zuniga-Trejos S, Gambardella V
J Exp Clin Cancer Res. 2025; 44(1):77.
PMID: 40022181
PMC: 11869439.
DOI: 10.1186/s13046-025-03308-8.
Notch and Hedgehog Signaling Unveiled: Crosstalk, Roles, and Breakthroughs in Cancer Stem Cell Research.
Iluta S, Nistor M, Buruiana S, Dima D
Life (Basel). 2025; 15(2).
PMID: 40003637
PMC: 11856057.
DOI: 10.3390/life15020228.
Prolonged DEHP exposure enhances the stemness and metastatic potential of TNBC cells in an MSI2-dependent manner.
Jadhao M, Hsu S, Deshmukh D, Liu P, Weng S, Chen Y
Int J Biol Sci. 2025; 21(4):1705-1729.
PMID: 39990676
PMC: 11844279.
DOI: 10.7150/ijbs.101598.
Pilot study: Initial investigation suggests differences in EMT-associated gene expression in breast tumor regions.
King K, Abdollahi H, Dinkel Z, Akins A, Valafar H, Dunn H
Comput Struct Biotechnol J. 2025; 27:548-555.
PMID: 39981295
PMC: 11840942.
DOI: 10.1016/j.csbj.2025.01.027.
Geniposide Inhibits Non-Small Cell Lung Cancer by Regulating Proliferation, Apoptosis, Invasion, Migration, Epithelial-Mesenchymal Transition, and Cancer Stem-Like Cell Property Via Wnt/β-Catenin Pathway.
He H, Li Y, Wang Y, Li M
Biochem Genet. 2025; .
PMID: 39964646
DOI: 10.1007/s10528-025-11030-5.
Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.
Sravani A, Thomas J
Heliyon. 2025; 11(3):e41964.
PMID: 39959483
PMC: 11830326.
DOI: 10.1016/j.heliyon.2025.e41964.
Transforming Growth Factor-β Modulates Cancer Stem Cell Traits on CD44 Subpopulations in Hepatocellular Carcinoma.
Aguilar-Chaparro M, Rivera-Pineda S, Hernandez-Galdamez H, Rios-Castro E, Garibay-Cerdenares O, Pina-Vazquez C
J Cell Biochem. 2025; 126(2):e70003.
PMID: 39943801
PMC: 11833284.
DOI: 10.1002/jcb.70003.
Long Non-Coding RNAs: Key Regulators of Tumor Epithelial/Mesenchymal Plasticity and Cancer Stemness.
Yuan Y, Tang Y, Fang Z, Wen J, Wicha M, Luo M
Cells. 2025; 14(3).
PMID: 39937018
PMC: 11817775.
DOI: 10.3390/cells14030227.
Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma.
Pham D, Hsu T
J Biomed Sci. 2025; 32(1):17.
PMID: 39920694
PMC: 11806631.
DOI: 10.1186/s12929-024-01111-9.
Cancer stem-like cells stay in a plastic state ready for tumor evolution.
Xu J, Zhang H, Nie Z, He W, Zhao Y, Huang Z
Neoplasia. 2025; 61:101134.
PMID: 39919692
PMC: 11851212.
DOI: 10.1016/j.neo.2025.101134.
Bacteria, stem cells and cancer.
Pani G
Cancer Gene Ther. 2025; .
PMID: 39915606
DOI: 10.1038/s41417-025-00876-x.
EMT-driven plasticity prospectively increases cell-cell variability to promote therapeutic adaptation in breast cancer.
Muller L, Fauvet F, Chassot C, Angileri F, Coutant A, Degletagne C
Cancer Cell Int. 2025; 25(1):32.
PMID: 39901189
PMC: 11789407.
DOI: 10.1186/s12935-025-03637-w.
PAX6 enhances Nanog expression by inhibiting NOTCH signaling to promote malignant properties in small cell lung cancer cells.
Guo X, Wang L, Zheng F, Li H
Heliyon. 2025; 11(2):e41795.
PMID: 39885876
PMC: 11780942.
DOI: 10.1016/j.heliyon.2025.e41795.
Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting restorative regimens.
Famta P, Shah S, Dey B, Kumar K, Bagasariya D, Vambhurkar G
Cancer Pathog Ther. 2025; 3(1):30-47.
PMID: 39872366
PMC: 11764040.
DOI: 10.1016/j.cpt.2024.01.001.
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics.
Das S, Samaddar S
Cancers (Basel). 2025; 17(2).
PMID: 39858036
PMC: 11764476.
DOI: 10.3390/cancers17020255.
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial-Mesenchymal Transition.
Blaszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak A
Cancers (Basel). 2025; 17(2).
PMID: 39858010
PMC: 11764116.
DOI: 10.3390/cancers17020228.